This article supports SDG's 3, 6, and 11 by illustrating the reduction of pollutants using various microbial techniques. Strategy and recommendations are summarized, along with the future prospects.
This content supports the SDG Goal 3: Good health and well-being by formulating an epidemiological mathematical model that demonstrates the transmission of the hepatitis B virus for use in research.
This Article supports Sustainable Development Goal 3 by examining whether psychological intervention for anxiety disorders is associated with a lower incidence of dementia. The results suggest that improvement in anxiety from these therapies was associated with reduced incidence of future dementia.
This article is NeuroView on blood-based biomarkers for AD and deployment in diverse settings
This Article supports Sustainable Development Goal 3 by developing a methodology for discriminating between and classifying Alzheimer's disease and frontotemporal dementia according to demographic, clinical, and cognitive data, across centres in Latin America. The approach provided high accuracy with the combination of classical statistical and machine learning procedures.
FGM is a violation of human rights. FGM affects girls'/women’s physical and psychological health.
Elsevier,
Overcoming Obstacles in Drug Discovery and Development
Surmounting the Insurmountable—Case Studies for Critical Thinking
2023, Pages 215-222
This content aligns with Goal 3: Good Health and Wellbeing by identifying the reactive metabolite responsible for the species-specific nephrotoxicity observed in rats dosed with efavirenz provide a framework for addressing nonclinical toxicities and clinical risk and providing a solid scientific basis for regulatory review.
Elsevier Health is launching an ambitious initiative called “The Year of the Zebra” to educate millions of current and future healthcare professionals, caregivers, researchers, patients, family members, and the general public about rare disorders.
In 2021, RELX continued to build on our strong corporate responsibility (CR) performance during the year, further improving on our key internal metrics and extending the scope of our unique contributions. This article is linked to SDGs 1,3,10,11,12,13 and 16, in line with RELX's areas of expertise.
Due to multiple cellular blocks in transcription, HIV-1 latency can only be reversed in a minor fraction of infected but potentially virus-producing CD4+ T cells from infected patients. New insights into the regulation of transcription elongation factor P-TEFb as a crucial rate-limiting step in the emergence of HIV-1 from latency may help design more effective latency reversal agents during HIV-1 infection.
